leisure time -WSS

leisure time

author：focus 2025-10-04 03:59:36 - browse：3

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： FDA early review: GLP

Wikipedia

WSS

Spinal cord stimulation reduces pain in amputees, study finds

Pregnancy discrimination could be enabled by AI

Male doctors called my cancer incurable. A female doctor showed it wasn't

Allen Institute goes after foundational questions, CEO Costa says

Nonprofit, backed by Microsoft, to certify AI tools in health care

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

leisure time

leisure time

focus

ChatGPT in medicine: STAT answers readers' burning questions

Boston Scientific acquires urology company Axonics for $3.7 billion

Trump demands the U.S. pay no more for drugs than other countries … again

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

After affirmative action ruling, medical educators look to 'holistic review'

Allen Institute goes after foundational questions, CEO Costa says

In Memoriam: Notable people who died in 2023

FDA needs staff influx to meet gene therapy needs, Marks says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA needs staff influx to meet gene therapy needs, Marks says

knowledge

AI models in health care face new federal disclosure requirements

Patients' immediate access to test results puts radiologists in a bind

JPM pitch from hospitals? Revenue streams outside of patient care

Spinal cord stimulation reduces pain in amputees, study finds

Hospital chaplains balance Covid safety with patients’ spiritual needs

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Wikipedia

Wikipedia

entertainment

Wikipedia